Hormone replacement therapy [topp]
Blood Pressure [orgf]
cardiovascular risk factor [dsyn]
Menopausal [phsf]
Women [popg]
Moderate [qlco]
Hypertension [dsyn]
Objective [inpr]
Injectable [bodm]
Hormone replacement therapy [topp]
placebo [topp]
hypertensive [fndg]
Menopausal [phsf]
Women [popg]
Design [acty]
Methods [inpr]
prospective [resa]
Double-Blind Study [resa]
>90 [qnco]
days [tmco]
Five [qnco]
Menopausal [phsf]
Women [popg]
Mild to moderate [qlco]
Hypertension [dsyn]
stopped [qlco]
Antihypertensive [phsu]
Medication [phsu]
Study [mnob]
2 Weeks [tmco]
diastolic bp [clna]
Increased [qnco]
mmHg [qnco]
Patients [podg]
included [ftcn]
Study [mnob]
Remaining [qlco]
Patients [podg]
Group [idcn]
placebo [topp]
Estradiol [horm, phsu, strd]
mg% [qnco]
Estradiol [horm, phsu, strd]
mg/mg [qnco]
Plus [qlco]
Prasterone [horm, phsu, strd]
P NOS [aapp, imft]
Five [qnco]
Patients [podg]
Excluded [idcn]
Study [mnob]
reasons [idcn]
Standing [phsf]
Recumbent [spco]
Decreased [qnco]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
Patients [podg]
Observed [ftcn]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
End [spco]
Trial [resa]
Plasma [bdsu]
renin activity [moft]
Aldosterone [horm, phsu, strd]
insulin levels [lbpr]
Decreased [qnco]
Study [mnob]
Plasma [bdsu]
renin activity [moft]
Fall [fndg]
P group [clna]
Aldosterone [horm, phsu, strd]
reduction [npop]
Highly significant [qlco]
Hormone [horm]
treated [topp]
Group [idcn]
P group [clna]
plasma insulin [lbpr]
Decreased [qnco]
Group [idcn]
fsh levels [lbtr]
treatment [ftcn]
Group [idcn]
Conclusions [idcn]
randomized controlled trial [inpr, resa]
>90 [qnco]
days [tmco]
hypertensive [fndg]
Women [popg]
forms [qlco]
Hormone replacement therapy [topp]
Fall [fndg]
Women [popg]
placebo [topp]
injections [topp]
